Conference Coverage (ASCO)
p53 Gene Therapy Successful in Phase II Study
Published in Gene Therapy Weekly, June 28th, 1999
Treatment options for recurrent head and neck cancer are limited and usually highly toxic. W. Jarrad Goodwin and colleagues from Rhone-Poulen Rorer, Pennsylvania, suggest that gene therapy represents a novel therapeutic approach that could target the disease at the molecular and cellular levels.
The researchers conducted a phase II trial of a gene therapy for head and neck cancer using a replication-deficient adenovirus carrying the p53 gene (Ad5CMV-p53). Current results were presented at the 35th Annual Meeting of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1999-06-28)
More Articles from Gene Therapy Weekly
- Damage Control
Gene Therapy May Help Injuries of the Central Nervous System - Emphysema Gene Therapy
Animal Model Facilitates Study of Interstitium Protein Delivery - Adjuvants
Bacterial CpG Motif Enhances T-Cell Response to Peptides - Psychosis
APO-E Genotype Linked to Psychosis, But Not Depression - Cystic Fibrosis (Screening)
CF Gene Undetected in Screening of Infertile Men - Genetic Testing (Liver Disease)
Testing Pregnant Women with Liver Illness Could Save Infant Lives - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
